Co-Diagnostics, Inc.
(NASDAQ : CODX)

( )
CODX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.04%202.891.3%$439.73m
BIIBBiogen Inc.
1.14%225.761.3%$382.28m
GILDGilead Sciences, Inc.
0.81%64.510.9%$362.26m
CELGCelgene Corporation
-0.18%100.391.3%$352.37m
ILMNIllumina, Inc.
2.56%310.313.5%$266.69m
REGNRegeneron Pharmaceuticals, Inc.
1.55%305.442.6%$219.74m
EXASExact Sciences Corporation
2.54%94.8524.1%$199.38m
ALXNAlexion Pharmaceuticals, Inc.
2.11%101.342.0%$181.06m
VRTXVertex Pharmaceuticals Incorporated
0.68%173.591.9%$178.83m
AAgilent Technologies, Inc.
-0.16%75.181.6%$153.77m
SRPTSarepta Therapeutics, Inc.
2.66%85.7014.6%$141.72m
ALDRAlder Biopharmaceuticals, Inc.
0.27%18.9210.2%$132.33m
BMRNBioMarin Pharmaceutical Inc.
-0.18%67.244.3%$95.95m
ACADACADIA Pharmaceuticals Inc.
-2.57%39.4813.4%$89.57m
SGENSeattle Genetics, Inc.
-0.22%82.426.2%$84.75m

Company Profile

Co-Diagnostics, Inc. is a molecular diagnostics company, which engages in the development, manufacture, and marketing of diagnostics technology. The company's products are utilized for tests that are designed using the detection and analysis of nucleic acid molecules. It also uses its proprietary technology to design tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.